Caldwell Sutter Capital, Inc. Viatris Inc Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q4 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 2,464 shares of VTRS stock, worth $21,461. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,464
Previous 1,967
25.27%
Holding current value
$21,461
Previous $22.8 Million
34.34%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VTRS
# of Institutions
1,143Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.24 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$807 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$555 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$545 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$511 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...